These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of investigational drugs in hospitals; a survey. I. TEPLITSKY B Hosp Prog; 1956 Aug; 37(8):76-82. PubMed ID: 13345319 [No Abstract] [Full Text] [Related]
4. The use of investigational drugs in hospitals; a survey. II. TEPLITSKY B Hosp Prog; 1956 Sep; 37(9):106; passim. PubMed ID: 13357155 [No Abstract] [Full Text] [Related]
5. Liability in use of investigational drugs. SCHREINER GE JAMA; 1963 Jul; 185():259-63. PubMed ID: 13987033 [No Abstract] [Full Text] [Related]
6. CONTROL EXPERIENCE WITH INVESTIGATIONAL NEW DRUGS. MEYERS EL Bull Parenter Drug Assoc; 1963; 17():27-37. PubMed ID: 14083963 [No Abstract] [Full Text] [Related]
7. The food and Drug Administration's view of investigational drugs. MEYERS EL SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340 [No Abstract] [Full Text] [Related]
8. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION. KELSEY FO J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363 [No Abstract] [Full Text] [Related]
10. INVESTIGATIONAL DRUG REGULATIONS AND CLINICAL RESEARCH. GIBSON ML J Oral Ther Pharmacol; 1964 Jul; 1():93-8. PubMed ID: 14204421 [No Abstract] [Full Text] [Related]
11. Problems relating to investigational drugs. KELSEY FO Am J Pharm Sci Support Public Health; 1963 Mar; 135():93-7. PubMed ID: 14031845 [No Abstract] [Full Text] [Related]
12. [Ethical hazards in the search for new drugs]. Godfraind MT Bull Mem Acad R Med Belg; 1993; 148(11 Pt 2):40-8. PubMed ID: 7987281 [No Abstract] [Full Text] [Related]
13. Problems relating to investigational drugs. Kelsey O Pharmakotherapia; 1964; 2(1):208-12. PubMed ID: 5875715 [No Abstract] [Full Text] [Related]
14. Drug innovation on the decline. Young D Am J Health Syst Pharm; 2007 Feb; 64(3):228, 231. PubMed ID: 17244865 [No Abstract] [Full Text] [Related]
16. Early access to new medicines. Breckenridge A; Walley T Clin Pharmacol Ther; 2008 Jul; 84(1):23-5. PubMed ID: 18288079 [No Abstract] [Full Text] [Related]
17. Substances doubtful for bulk drug substances list could be INDs. Thompson CA Am J Health Syst Pharm; 2016 Apr; 73(8):512-4. PubMed ID: 27045058 [No Abstract] [Full Text] [Related]
18. Biosimilars: considerations for an abbreviated pathway. Kozlowski S; Behrman R Leuk Lymphoma; 2009 Apr; 50(4):527-8. PubMed ID: 19373649 [No Abstract] [Full Text] [Related]